BiotechTube
Home/Avata Biosciences/Dr. Andrew Saich
DA

Dr. Andrew Saich

Chief Medical Officer & Cofounder

Avata Biosciences

Therapeutic Areas

EpilepsySchizophreniaAddictionNeurologyPsychiatry

Avata Biosciences Pipeline

DrugIndicationPhase
AVAT-021Adult Focal EpilepsyPhase 2
AVAT-021 (Pediatric)Pediatric Focal EpilepsyPreclinical/Phase 1
AVAT-022Pediatric Focal EpilepsyDiscovery/Preclinical
AVAT-031SchizophreniaDiscovery
AVAT-041Opioid Sparing/AddictionDiscovery

Leadership Team at Avata Biosciences

JB
Julian Bryson
Executive Chairman & Cofounder
RH
Rupert Haynes
Chief Executive Officer & Cofounder
DV
Dr. Venkat Goskonda
Chief Scientific Officer
GP
Grace Powell
Head of Regulatory Affairs
DC
Dr. Chris Hayes
Head of Intellectual Property
JG
Jim Gillespie
Program Director
DE
Dr. Emma Cheetham
Patent Portfolio Director
View full Avata Biosciences profile